Body Weight Loss After Surgery is an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer

Aoyama, Toru; Yoshikawa, Takaki; Shirai, Junya; Hayashi, Tsutomu; Yamada, Takanobu; Tsuchida, Kazuhito; Hasegawa, Shinichi; Cho, Haruhiko; Yukawa, Norio; Oshima, Takashi; Rino, Yasushi; Masuda, Munetaka; Tsuburaya, Akira
June 2013
Annals of Surgical Oncology: An Oncology Journal for Surgeons;Jun2013, Vol. 20 Issue 6, p2000
Academic Journal
No abstract available.


Related Articles

  • Intraoperative Blood Loss is a Critical Risk Factor for Peritoneal Recurrence After Curative Resection of Advanced Gastric Cancer. Kamei, Takao; Kitayama, Joji; Yamashita, Hiroharu; Nagawa, Hirokazu // World Journal of Surgery;Jun2009, Vol. 33 Issue 6, p1240 

    Perioperative blood transfusion has been shown to be associated with poor outcome in various types of malignancy. However, the relationship between the amount of blood loss and specific types of cancer recurrence has not been documented. We retrospectively examined the amount of intraoperative...

  • Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small-cell lung cancer. Katsuhiko Shimizu; Riki Okita; Shinsuke Saisho; Takuro Yukawa; Ai Maeda; Yuji Nojima; Masao Nakata // Therapeutics & Clinical Risk Management;2015, Vol. 11, p1555 

    Background: Adjuvant chemotherapy after the complete resection of non-small-cell lung cancer (NSCLC) is now the standard of care. To improve survival, it is important to identify risk factors for the continuation of adjuvant chemotherapy. In this study, we analyzed chemotherapy...

  • Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer.  // JAMA: Journal of the American Medical Association;5/5/2010, Vol. 303 Issue 17, p1729 

    The article discusses a study which quantified the possible benefit of chemotherapy after complete resection over surgery alone in terms of overall survival and disease-free survival. The researchers conducted an individual patient-level meta-analysis of all randomized clinical trials (RCTs)...

  • Defining a high-risk subgroup of pathological T2N0 gastric cancer by prognostic risk stratification for adjuvant therapy. Du, Chunyan; Zhou, Ye; Huang, Kai; Zhao, Guangfa; Fu, Hong; Shi, Yingqiang // Journal of Gastrointestinal Surgery;Dec2011, Vol. 15 Issue 12, p2153 

    Background: Adjuvant therapy is not usually recommended in AJCC T2N0M0 gastric cancer, yet sometimes is indicated for high-risk patients. The purpose of this study is to stratify the risk of pathological T2N0 gastric cancer after gastrectomy based on clinicopathological factors so...

  • Chemotherapy for Advanced Gastric Cancer: Review and Update of Current Practices. Sung Chul Park; Hoon Jai Chun // Gut & Liver;Jul2013, Vol. 7 Issue 4, p385 

    No standard adjuvant or palliative chemotherapy regimen has been internationally approved for patients with advanced gastric cancer. Adjuvant chemoradiotherapy is administered prior to surgery and is used in the Unitied States, and intensified chemotherapy is administered prior to and after...

  • Overweight is a risk factor for surgical site infection following distal gastrectomy for gastric cancer. Hirao, Motohiro; Tsujinaka, Toshimasa; Imamura, Hiroshi; Kurokawa, Yukinori; Inoue, Kentaro; Kimura, Yutaka; Shimokawa, Toshio; Furukawa, Hiroshi // Gastric Cancer;Apr2013, Vol. 16 Issue 2, p239 

    Background: Our objective was to assess the risk factors for surgical site infections (SSIs) in gastric surgery using the results of the Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG) 0501 phase 3 trial. Methods: The OGSG 0501 trial was conducted to compare standard prophylactic...

  • Body weight changes in breast cancer patients following adjuvant chemotherapy and contributing factors. JIAN-SHENG WANG; HUI CAI; CHANG-YAN WANG; JIA ZHANG; MING-XIN ZHANG // Molecular & Clinical Oncology;2014, Vol. 2 Issue 1, p105 

    Weight gain commonly occurs in breast cancer patients who receive adjuvant chemotherapy. Weight gain may cause psychosocial stress and is associated with patient prognosis and survival. Several factors contributing to weight gain have been identified in Western populations. However, there was...

  • Risk factors for 6-month continuation of S-1 adjuvant chemotherapy for gastric cancer. Aoyama, Toru; Yoshikawa, Takaki; Hayashi, Tsutomu; Kuwabara, Hiroshi; Mikayama, Yo; Ogata, Takashi; Cho, Haruhiko; Tsuburaya, Akira // Gastric Cancer;Apr2013, Vol. 16 Issue 2, p133 

    Background: The factors that affect the 6-month continuation of adjuvant chemotherapy with S-1 have not been fully evaluated. The objective of this retrospective study was to clarify the risk factors for 6-month continuation of S-1 adjuvant chemotherapy. Methods: The study selected patients who...

  • Bariatric Surgery - Effects on Obesity and Related co-Morbidities. Svane, Maria Saur; Madsbad, Sten // Current Diabetes Reviews;May2014, Vol. 10 Issue 3, p208 

    Laparoscopic adjustable gastric banding (LAGB), laparoscopic Roux-en-Y gastric bypass (RYGB) and laparoscopic sleeve gastrectomy (SG) are the three most commonly performed bariatric procedures. Obesity responds well to bariatric surgery, with major long-lasting weight loss that is most...

  • Obesity as an Adverse Prognostic Factor for Patients Receiving Adjuvant Chemotherapy for Breast Cancer. Bastarrachea, Jorge; Hortobagyi, Gabriel N.; Smith, Terry L.; Kau, Shu-Wan C.; Buzdar, Aman U. // Annals of Internal Medicine;1/1/94, Vol. 120 Issue 1, p18 

    Objective: To determine whether obesity is an independent prognostic factor among women receiving adjuvant chemotherapy for lymph node-positive breast cancer and to determine how obesity relates to other commonly used prognostic indicators. Design: Retrospective review of the clinical...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics